---
title: "EU adds severe allergies as side effect of Novavax Covid-19 vaccine"
description: "July 14 (Reuters) - The European Medicines Agency on Thursday identified severe allergic reactions as potential side effects of Novavax Inc's NVAX.O Covid-19 vaccine."
type: "NewsArticle"
publisher: "Daily Maverick"
site: "https://www.dailymaverick.co.za"
section: "COVID-19"
author: "Reuters"
author_url: "https://www.dailymaverick.co.za/author/reuters/"
canonical_url: "https://www.dailymaverick.co.za/article/2022-07-18-eu-adds-severe-allergies-as-side-effect-of-novavax-covid-19-vaccine/"
published: "2022-07-18T10:40:14"
lang: "en-ZA"
word_count: 128
---

# EU adds severe allergies as side effect of Novavax Covid-19 vaccine

> July 14 (Reuters) - The European Medicines Agency on Thursday identified severe allergic reactions as potential side effects of Novavax Inc's NVAX.O Covid-19 vaccine.

By Reuters · Published 18 July 2022, 12:40 SAST

## Content

The vaccine was authorized by U.S. regulators on Wednesday, and its product label in the United States warns against administering the shot to people with a history of allergic reactions to any components of the shot.

Shares of Novavax fell 20.3% to $55.72 in morning trading, along with the broader market and other Covid-19 vaccine makers. Novavax shares are usually volatile.

The EMA said it would also update the product information for the vaccine to add unusual or decreased feeling in the skin as a new side effect.

Only 250,000 doses of Novavax's Covid-19 vaccine, Nuvaxovid, have been administered in Europe so far since its launch in December, according to the European Centre for Disease Prevention and Control.

(Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)